Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Sonneveld, Myrthe E ^a,b   De Haas, Masja ^c   Koeleman, Carolien ^d   De Haan, Noortje ^d   Zeerleder, Sacha S ^b   Ligthart, Peter C ^c   Wuhrer, Manfred ^d   Van Der Schoot, C Ellen ^a,b   Vidarsson, Gestur ^a,b  

^a SANQUIN RESEARCH   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; POLYSACCHARIDE;

AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD; ERYTHROCYTE; FEMALE; GLYCOSYLATION; HEMOLYSIS; HUMAN; IMMUNOLOGY; MALE; MASS SPECTROMETRY; METABOLISM; SEVERITY OF ILLNESS INDEX;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; AUTOANTIBODIES; ERYTHROCYTES; FEMALE; GLYCOSYLATION; HEMOLYSIS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MALE; MASS SPECTROMETRY; POLYSACCHARIDES; SEVERITY OF ILLNESS INDEX;

EID: 85027531512     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-08654-y     Document Type: Article

References (40)

1. Barcellini, W. New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia. Transfus Med Hemother 42, 287-293, doi:10.1159/000439002 (2015).
2. Barros, M. M., Blajchman, M. A. & Bordin, J. O. Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment. Transfus Med Rev 24, 195-210, doi:10.1016/j.tmrv.2010.03.002 (2010).
3. Bass, G. F., Tuscano, E. T. & Tuscano, J. M. Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev 13, 560-564, doi:10.1016/j.autrev.2013.11.010 (2014).
4. Meulenbroek, E. M., Wouters, D. & Zeerleder, S. S. Lyse or not to lyse: Clinical significance of red blood cell autoantibodies. Blood Rev 29, 369-376, doi:10.1016/j.blre.2015.05.001 (2015).
5. Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5, 520, doi:10.3389/fimmu.2014.00520 (2014).
6. Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M. & Dwek, R. A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol 25, 21-50, doi:10.1146/annurev.immunol.25.022106.141702 (2007).
7. Houde, D., Peng, Y., Berkowitz, S. A. & Engen, J. R. Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol Cell Proteomics 9, 1716-1728, doi:10.1074/mcp.M900540-MCP200 (2010).
8. Yamada, K. et al. Galactosylation of IgG1 modulates FcgammaRIIB-mediated inhibition of murine autoimmune hemolytic anemia. J Autoimmun 47, 104-110, doi:10.1016/j.jaut.2013.09.001 (2013).
9. Ito, K. et al. Lack of galactosylation enhances the pathogenic activity of IgG1 but Not IgG2a anti-erythrocyte autoantibodies. J Immunol 192, 581-588, doi:10.4049/jimmunol.1302488 (2014).
10. Quast, I. et al. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J Clin Invest 125, 4160-4170, doi:10.1172/JCI82695 (2015).
11. Malhotra, R. et al. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannosebinding protein. Nat Med 1, 237-243 (1995).
12. Pace, D. et al. Characterizing the effect of multiple Fc glycan attributes on the effector functions and FcgammaRIIIa receptor binding activity of an IgG1 antibody. Biotechnol Prog. doi:10.1002/btpr.2300 (2016).
13. Bakovic, M. P. et al. High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides. J Proteome Res 12, 821-831, doi:10.1021/pr300887z (2013).
14. Biermann, M. H. et al. Sweet but dangerous-the role of immunoglobulin G glycosylation in autoimmunity and inflammation. Lupus 25, 934-942, doi:10.1177/0961203316640368 (2016).
15. Bondt, A. et al. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J Proteome Res 12, 4522-4531, doi:10.1021/pr400589m (2013).
16. Kapur, R. et al. Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn. Br. J. Haematol. 166, 936-945 (2014).
17. Wuhrer, M. et al. Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens. J Proteome Res 8, 450-456, doi:10.1021/pr800651j (2009).
18. Kapur, R. et al. A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy. Blood 123, 471-480, doi:10.1182/blood-2013-09-527978 (2014).
19. Sonneveld, M. E. et al. Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia. Br J Haematol. doi:10.1111/bjh.14053 (2016).
20. Ackerman, M. E. et al. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest 123, 2183-2192, doi:10.1172/JCI65708 (2013).
21. Wang, T. T. et al. IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity. Science 355, 395-398, doi:10.1126/science.aai8128 (2017).
22. Nightingale, M. J. et al. The value to blood establishments of supplier quality audit and of adopting a European Blood Alliance collaborative approach. Blood Transfus 12, 91-98, doi:10.2450/2013.0208-13 (2014).
23. Saeland, E. et al. Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J Immunol 170, 6158-6164 (2003).
24. Stapleton, N. M. et al. Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat Commun 2, 599, doi:10.1038/ncomms1608 (2011).
25. Falck, D. et al. Glycoforms of Immunoglobulin G Based Biopharmaceuticals Are Differentially Cleaved by Trypsin Due to the Glycoform Influence on Higher-Order Structure. J Proteome Res 14, 4019-4028, doi:10.1021/acs.jproteome.5b00573 (2015).
26. Einarsdottir, H. K. et al. Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G. Glycoconj J 30, 147-157, doi:10.1007/s10719-012-9381-6 (2013).
27. Plomp, R. et al. Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3). Mol Cell Proteomics 14, 1373-1384, doi:10.1074/mcp.M114.047381 (2015).
28. Selman, M. H. et al. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface. J Proteomics 75, 1318-1329, doi:10.1016/j.jprot.2011.11.003 (2012).
29. Rombouts, Y. et al. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis 74, 234-241, doi:10.1136/annrheumdis-2013-203565 (2015).
30. Sonneveld, M. E. et al. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn. Br J Haematol. doi:10.1111/bjh.14438 (2016).
31. Koelewijn, J. M., Vrijkotte, T. G., van der Schoot, C. E., Bonsel, G. J. & de Haas, M. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 48, 941-952, doi:10.1111/j.1537-2995.2007.01625.x (2008).
32. Hodoniczky, J., Zheng, Y. Z. & James, D. C. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol Prog 21, 1644-1652, doi:10.1021/bp050228w (2005).
33. Ruhaak, L. R. et al. Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity. PLoS One 5, e12566, doi:10.1371/journal.pone.0012566 (2010).
34. Hadley, A. G. et al. The glycosylation of red cell autoantibodies affects their functional activity in vitro. Br J Haematol 91, 587-594 (1995).
35. Thomann, M. et al. In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity. PLoS One 10, e0134949, doi:10.1371/journal.pone.0134949 (2015).
36. Barker, R. N., Leader, K. A. & Elson, C. J. Serial changes in the galactosylation of autoantibodies and serum IgG in autoimmune haemolytic anaemia. Autoimmunity 31, 103-108 (1999).
37. van de Geijn, F. E. et al. Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: results from a large prospective cohort study. Arthritis Res Ther 11, R193, doi:10.1186/ar2892 (2009).
38. de Jong, S. E. et al. IgG1 Fc N-glycan galactosylation as a biomarker for immune activation. Sci Rep 6, 28207, doi:10.1038/srep28207 (2016).
39. Packman, C. H. The Clinical Pictures of Autoimmune Hemolytic Anemia. Transfus Med Hemother 42, 317-324, doi:10.1159/000440656 (2015).
40. Zeerleder, S. Autoimmune haemolytic anaemia-a practical guide to cope with a diagnostic and therapeutic challenge. Neth J Med 69, 177-184 (2011).